Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Totzeck

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Basic Research in Cardiology|February 5, 2026
Remote ischemic conditioning for safe cardioprotection in cardio-oncology?Matthias Totzeck, Tienush Rassaf
JACC. Cardiooncology|May 22, 2024
Natriuretic Peptides and Troponins: Sufficient Monitoring of Cancer Survivors?Matthias Totzeck, Tienush Rassaf
Herz|February 21, 2020
[Novel cancer treatment and the cardiovascular risk : What should cardiologists know?]Matthias Totzeck, Tienush Rassaf
Journal of Thoracic Disease|February 1, 2019
Modern concepts in cardio-oncologyTienush Rassaf, Matthias Totzeck
European Heart Journal|November 25, 2025
Myotoxicity after immunotherapy: not so rare, not so benignMatthias Totzeck, Tienush Rassaf
Critical Care Medicine|June 21, 2011
Endothelial damage after resuscitation: reactive oxygen species as possible therapeutic targets?Matthias Totzeck, Malte Kelm, Tienush Rassaf
International Journal of Cardiology. Heart & Vasculature|September 14, 2019
Cardiotoxicity from immune checkpoint inhibitorsLars Michel, Tienush Rassaf, Matthias Totzeck
Basic Research in Cardiology|October 21, 2021
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicityLars Michel, Matthias Totzeck, Tienush Rassaf
European Heart Journal. Case Reports|April 26, 2019
Malaise and fatigue following mitral valve repair: case reportLena Hinrichs, Tienush Rassaf, Matthias Totzeck
Journal of Thoracic Disease|February 1, 2019
Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicityLars Michel, Tienush Rassaf, Matthias Totzeck
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Basic Research in Cardiology|February 5, 2026
Remote ischemic conditioning for safe cardioprotection in cardio-oncology?Matthias Totzeck, Tienush Rassaf
JACC. Cardiooncology|May 22, 2024
Natriuretic Peptides and Troponins: Sufficient Monitoring of Cancer Survivors?Matthias Totzeck, Tienush Rassaf
Herz|February 21, 2020
[Novel cancer treatment and the cardiovascular risk : What should cardiologists know?]Matthias Totzeck, Tienush Rassaf
Journal of Thoracic Disease|February 1, 2019
Modern concepts in cardio-oncologyTienush Rassaf, Matthias Totzeck
European Heart Journal|November 25, 2025
Myotoxicity after immunotherapy: not so rare, not so benignMatthias Totzeck, Tienush Rassaf
Critical Care Medicine|June 21, 2011
Endothelial damage after resuscitation: reactive oxygen species as possible therapeutic targets?Matthias Totzeck, Malte Kelm, Tienush Rassaf
International Journal of Cardiology. Heart & Vasculature|September 14, 2019
Cardiotoxicity from immune checkpoint inhibitorsLars Michel, Tienush Rassaf, Matthias Totzeck
Basic Research in Cardiology|October 21, 2021
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicityLars Michel, Matthias Totzeck, Tienush Rassaf
European Heart Journal. Case Reports|April 26, 2019
Malaise and fatigue following mitral valve repair: case reportLena Hinrichs, Tienush Rassaf, Matthias Totzeck
Journal of Thoracic Disease|February 1, 2019
Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicityLars Michel, Tienush Rassaf, Matthias Totzeck
Pageof 15